Dr. Lal PathLabs to Host Q1 FY27 Earnings Conference Call
Dr. Lal PathLabs Limited (DLPL) has announced that it will host a conference call on Friday, July 24, 2026, to discuss its financial and operating performance for the first quarter of fiscal year 2027. The call is scheduled to begin at 5:30 P.M. (IST).The management team representing the company during the call will include (Hony) Brig. Dr. Arvind Lal, Executive Chairman; Mr. Shankha Banerjee, Chief Executive Officer; and Mr. Ved Prakash Goel, Group Chief Financial Officer and CEO of International Business.
During the session, the management will provide a brief discussion on the financial results and operational performance for Q1 FY27, which are set to be announced on the same day as the call. Participants will have the opportunity to ask questions and have their queries addressed by the leadership team following the initial presentation.
The conference call details are structured as follows:
| Category | Details |
|---|---|
| Time | 5:30pm IST on Friday, July 24, 2026 |
| Universal Access | +91 22 6280 1141; +91 22 7115 8042 |
| International Toll Number (USA) | 18667462133 |
| International Toll Number (UK) | 08081011573 |
| International Toll Number (Singapore) | 8001012045 |
Dr. Lal PathLabs Limited serves as a prominent consumer healthcare brand in India, providing an integrated nationwide network for diagnostic services. The company offers a wide range of tests for individual patients, hospitals, and corporate clients. As of March 31, 2026, the service catalog included 525 test panels, 3,130 pathology tests, and 1,173 radiology and cardiology tests.
The operational reach of Dr. Lal PathLabs remains significant. As of March 31, 2026, the company operated 312 clinical labs, including National Reference Labs in Delhi and Regional Reference Labs in Kolkata, Bangalore, and Mumbai. The infrastructure also includes 7,727 Patient Service Centers (PSCs) and 13,935 Pick-up Points (PUPs).
The company reported substantial scale in its recent operations. In FY26, the firm collected and processed approximately 94.5 million samples from 30.3 million patients. In FY25, it handled 85.6 million samples from 28.8 million patients.
LALPATHLAB Stock Price Movement
As of 1:29 PM, shares of Dr. Lal Path Labs Ltd. are slipping by 2.15% in live trading, currently at ₹1695.5. The stock has seen a turnover of 162,849 shares while finding support near the ₹1666.2 mark during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.